Effect of dipeptidyl peptidase-4 inhibitor in patients undergoing bypass surgery

Conclusions Dipeptidyl-peptidase-4 inhibitors reduced the incidence of major adverse cardiac and cerebrovascular events and improved the long-term prognosis after coronary artery bypass in patients with type 2 diabetes mellitus.

http://aan.sagepub.com/cgi/content/abstract/24/9/863?rss=1

Source: Asian Cardiovascular and Thoracic Annals - November 6, 2016 Category: Cardiology Authors: Ogawa, S., Okawa, Y., Sawada, K., Goto, Y., Fukaya, S., Suzuki, T. Tags: Cardiac Source Type: research